NYLI Candriam Emerging Markets Equity Investor Class
MCYVX
NASDAQ
Weiss Ratings | MCYVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Weak | |||
Reward Grade | D | |||
Risk Index | Weak | |||
Risk Grade | D+ | |||
Company Info | MCYVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | New York Life Investment Management LLC | |||
Manager/Tenure (Years) | Mohamed Lamine Saidi (7), Philip Screve (7), Paulo Salazar (4) | |||
Website | http://www.nylim.com/institutional | |||
Fund Information | MCYVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | NYLI Candriam Emerging Markets Equity Investor Class | |||
Category | Diversified Emerging Mkts | |||
Sub-Category | Global Emerging Markets Equity | |||
Prospectus Objective | Diversified Emerging Markets | |||
Inception Date | Nov 15, 2017 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | 2,500.00 | |||
Minimum Subsequent Investment | 50.00 | |||
Front End Fee | 0.05 | |||
Back End Fee | -- | |||
Dividends and Shares | MCYVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 0.12% | |||
Dividend | MCYVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 2.27% | |||
Asset Allocation | MCYVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 1.37% | |||
Stock | 98.63% | |||
U.S. Stock | 0.60% | |||
Non-U.S. Stock | 98.03% | |||
Bond | 0.00% | |||
U.S. Bond | 0.00% | |||
Non-U.S. Bond | 0.00% | |||
Preferred | 0.00% | |||
Convertible | 0.00% | |||
Other Net | 0.00% | |||
Price History | MCYVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.57% | |||
30-Day Total Return | 3.61% | |||
60-Day Total Return | 6.29% | |||
90-Day Total Return | 13.65% | |||
Year to Date Total Return | 19.96% | |||
1-Year Total Return | 21.06% | |||
2-Year Total Return | 39.49% | |||
3-Year Total Return | 33.16% | |||
5-Year Total Return | 17.27% | |||
Price | MCYVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | -- | |||
1-Month Low Price | -- | |||
1-Month High Price | -- | |||
52-Week Low Price | -- | |||
52-Week Low Price (Date) | -- | |||
52-Week High Price | -- | |||
52-Week High Price (Date) | -- | |||
NAV | MCYVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Nav | $12.32 | |||
1-Month Low NAV | $11.60 | |||
1-Month High NAV | $12.32 | |||
52-Week Low NAV | $9.08 | |||
52-Week Low NAV (Date) | Apr 08, 2025 | |||
52-Week High NAV | $12.32 | |||
52-Week High Price (Date) | Aug 25, 2025 | |||
Beta / Standard Deviation | MCYVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.92 | |||
Standard Deviation | 16.40 | |||
Balance Sheet | MCYVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 108.94M | |||
Operating Ratios | MCYVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 1.48% | |||
Turnover Ratio | 101.00% | |||
Performance | MCYVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 6.54% | |||
Last Bear Market Total Return | -14.52% | |||